480 related articles for article (PubMed ID: 25854654)
1. Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis.
Zhang J; Chen Z; Zheng J; Breusch SJ; Tian J
Arch Orthop Trauma Surg; 2015 Jun; 135(6):759-72. PubMed ID: 25854654
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
3. Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program.
Jenny JY; Bulaid Y; Boisrenoult P; Bonin N; Henky P; Tracol P; Chouteau J; Courtin C; Henry MP; Schwartz C; Mertl P; De Ladoucette A;
Orthop Traumatol Surg Res; 2020 Dec; 106(8):1533-1538. PubMed ID: 33127330
[TBL] [Abstract][Full Text] [Related]
4. Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study.
Sloan M; Sheth N; Lee GC
Clin Orthop Relat Res; 2019 Mar; 477(3):523-532. PubMed ID: 30624321
[TBL] [Abstract][Full Text] [Related]
5. Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?
Warren JA; Sundaram K; Anis HK; Kamath AF; Higuera CA; Piuzzi NS
J Arthroplasty; 2020 Jan; 35(1):259-264. PubMed ID: 31530463
[TBL] [Abstract][Full Text] [Related]
6. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
7. Gender differences of venous thromboembolism risk after total hip and total knee arthroplasty: a meta-analysis.
Lu Y; Zhou ZY; Liu YK; Chen HL; Yang HL; Liu F
J Thromb Thrombolysis; 2016 May; 41(4):556-62. PubMed ID: 26446589
[TBL] [Abstract][Full Text] [Related]
8. Is Apixaban Safe and Effective for Venous Thromboembolism Prophylaxis After Primary Total Hip and Total Knee Arthroplasties?
Rooney T; Barrack RL; Clohisy JC; Nunley RM; Lawrie CM
J Arthroplasty; 2021 Jul; 36(7S):S328-S331. PubMed ID: 33888386
[TBL] [Abstract][Full Text] [Related]
9. Occult Left Common Iliac Vein Compression Increases Postoperative Venous Thromboembolism Risk Following Total Hip Arthroplasty.
Bergen MA; Wall KC; Kim CY; Garrigues GE
J Arthroplasty; 2019 Feb; 34(2):375-378. PubMed ID: 30448323
[TBL] [Abstract][Full Text] [Related]
10. The incidence of symptomatic in-hospital VTEs in Asian patients undergoing joint arthroplasty was low: a prospective, multicenter, 17,660-patient-enrolled cohort study.
Zeng Y; Si H; Wu Y; Yang J; Zhou Z; Kang P; Pei F; Shen B
Knee Surg Sports Traumatol Arthrosc; 2019 Apr; 27(4):1075-1082. PubMed ID: 30386998
[TBL] [Abstract][Full Text] [Related]
11. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Arsoy D; Giori NJ; Woolson ST
Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
[TBL] [Abstract][Full Text] [Related]
12. Venous Thromboembolism despite Ongoing Prophylaxis after Fast-Track Hip and Knee Arthroplasty: A Prospective Multicenter Study of 34,397 Procedures.
Petersen PB; Jørgensen CC; Kehlet H;
Thromb Haemost; 2019 Nov; 119(11):1877-1885. PubMed ID: 31587249
[TBL] [Abstract][Full Text] [Related]
13. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
14. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty.
Deng W; Huo L; Yuan Q; Huang D; Li Q; Tian W
BMC Musculoskelet Disord; 2021 Jul; 22(1):608. PubMed ID: 34229632
[TBL] [Abstract][Full Text] [Related]
16. A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
Johnson SA; Jones AE; Young E; Jennings C; Simon K; Fleming RP; Witt DM
Thromb Res; 2021 Oct; 206():120-127. PubMed ID: 34455129
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.
Nadi S; Vreugdenburg TD; Atukorale Y; Ma N; Maddern G; Rovers M
ANZ J Surg; 2019 Oct; 89(10):1204-1210. PubMed ID: 30989803
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years.
Zhang ZH; Shen B; Yang J; Zhou ZK; Kang PD; Pei FX
BMC Musculoskelet Disord; 2015 Feb; 16():24. PubMed ID: 25887100
[TBL] [Abstract][Full Text] [Related]
19. The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty.
Tyagi V; Tomaszewski P; Lukasiewicz A; Theriault S; Pelker R
Orthopedics; 2018 Jan; 41(1):e98-e103. PubMed ID: 29156069
[TBL] [Abstract][Full Text] [Related]
20. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.
Wu PK; Chen CF; Chung LH; Liu CL; Chen WM
Thromb Res; 2014 May; 133(5):719-24. PubMed ID: 24593913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
